In this issue:
Managing ASCT-eligible patients with newly diagnosed MM
Managing ASCT-ineligible patients with newly diagnosed MM
Prevention and treatment of VTE in patients with MM
Treating MBD
Teclistamab management for RRMM
Bispecific antibody therapy for MM
MBS changes
PBS co-payments
PBAC November 2025 meeting outcomes
1800MEDICARE
Quadruplet treatment regimens for newly diagnosed MM
Future of MM with AI and digital twins
Conferences & Workshops
Please login below to download this issue (PDF)